SEC Form D private-offering filing

iQure Pharma Inc.

Name: iQure Pharma Inc. - new SEC Form D private-offering filing, Skillman, NJ
Published: 2026-06-03

A new SEC Form D private-offering notice from Skillman, NJ, a $4,000,000 filer-stated offering target in Biotech. The source filing is one click away.

iQure Pharma Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing astrocyte targeted EAAT2 modulator therapeutics for CNS disorders including epilepsy, Parkinson's disease, migraine and ALS.

Filed 2026-06-03Filed to raise $4,000,000First money in 2026-05-27Raised so far $650,000HQ (as filed) Skillman, NJSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified iqurepharma.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.